Podcasts & RSS Feeds
Most Active Stories
- What's Next For Pensions, Now That Court Has Tossed Illinois' Law?
- Power Players – Who’s In And Who’s Out When It Comes To Lobbying The New Governor
- Lawmakers Propose Adding Crime Victims' Bill Of Rights To Illinois Law
- How Much Is Your AP Test Score Worth In Illinois? The Answer Varies By University
- New Pension Fixes May Emerge; Rauner Considering Ideas That "Haven't Been Brought Forward Yet"
Tue December 17, 2013
Glaxo To Stop Paying Doctors To Promote Drugs
Originally published on Tue December 17, 2013 11:30 pm
LINDA WERTHEIMER, HOST:
NPR's business news starts with new rules for Glaxo.
(SOUNDBITE OF MUSIC)
WERTHEIMER: The head of British - the British drug maker GlaxoSmithKline, told The New York Times yesterday that the company will stop paying doctors to promote its drugs. Pharmaceutical firms commonly pay physicians to speak at medical conferences - a practice criticized as a conflict of interest.
Glaxo's CEO told the company - told the paper - the company would also stop paying all its sales reps based on how many prescriptions doctors write. Transcript provided by NPR, Copyright NPR.